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(arterial and venous blood, bronchoalveolar la-
vage, urine) yielded negative results. High doses 
of corticosteroids were initiated and an enzyme- 
-linked immunosorbent assay for serum antinu-
clear antibodies and an immunoprecipitation as-
say for autoimmune inflammatory myopathy se-
rum antibodies were performed. 
Despite treatment and modifications of venti-
lator settings, pulmonary compliance (respirato-
ry rate, 30 bpm; tidal volume, ≈410 ml; peak in-
spiratory pressure, 34 cm H2O) and arterial blood 
oxygenation decreased with signs of severe respi-
ratory acidosis (PaO2, 67.7 mmHg; PaCO2, 95.7 
mmHg; pH, 7.08; FiO2, 1.0). On hospital day 5, 
prone ventilation was started but no significant 
improvement in respiratory function parameters 
was observed. Veno venous extracorporeal mem-
brane oxygenation was introduced (FIGURE 1B). 
Despite these efforts, the patient’s status dete-
riorated rapidly with the development of multi-
organ dysfunction (acute kidney injury, liver fail-
ure) and excessive bleeding, most probably due 
to disseminated intravascular coagulation. Pre-
viously ordered autoantibody tests were highly 
positive for anti -MDA5 antibodies. The patient 
died on day 8. On autopsy, a gross examination 
revealed an uneven surface of the visceral pleura 
as well as increased density and evidence of abun-
dant congestion of both lungs. Features of inter-
stitial pneumonia were confirmed by a histologi-
cal examination. A total of 6 samples were taken, 
3 from each lung. Specimens showed diffuse in-
volvement of lung parenchyma by severe gener-
alized interstitial fibrosis (FIGURE 1C) with mild-to-
moderate (predominantly lymphocytic) inflam-
matory infiltrate (FIGURE 1D).
The pattern described above is most consistent 
with a fibrotic variant of nonspecific interstitial 
Clinically amyopathic dermatomyositis (CADM) 
is a unique subset of dermatomyositis, with 
typical skin manifestations of dermatomyosi-
tis but little or no evidence of muscle inflam-
mation.1,2 CADM may be complicated by rapid-
ly progressive interstitial lung disease, which is 
usually life-threatening and resistant to immu-
nosuppressive therapy.3 Anti-MDA5 antibod-
ies (also known as CADM-140) have been de-
scribed in dermatomyositis, especially in CADM.4 
Anti-MDA5-positive patients are characterized by 
rapidly progressive interstitial lung disease and a 
very high mortality rate at 6 months.5 Interest-
ingly, the role of anti MDA-5 antibodies in Cau-
casian population is not well established.
A 59-year-old man with a 3-week history of 
nonproductive cough, fever, fatigue, and swol-
len joints was hospitalized with an initial diag-
nosis of acute pneumonia. On admission, a chest 
computed tomography scan revealed bilateral in-
filtrations with atelectasis in the lower lobes of 
the lungs (FIGURE 1A). During the first hospital 
day, the patient’s condition rapidly deteriorated 
with increased tachypnea. An arterial gas analy-
sis showed a pH of 7.26, pO2 of 55 mmHg, and 
pCO2 of 62 mmHg. He was transferred to an in-
tensive care unit where he was intubated and me-
chanical ventilation was initiated. 
On admission to the intensive care unit, sever-
al signs suggesting amyopathic dermatomyositis 
such as mechanic’s hands, Gottron sign, and pal-
mar papules were noted. Laboratory tests showed 
no evidence of myositis (creatine kinase levels 
were within the reference range, while the levels 
of alanine transaminase and aspartate transami-
nase were slightly elevated). A wide-spectrum an-
timicrobial treatment started earlier was modi-
fied and continued but all microbiological cultures 
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pneumonia. Changes in other organs included fo-
cal, nonspecific areas of fibrosis in the myocardi-
um and moderate steatosis of the liver.
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FIGURE 1 A – a lung computed tomography scan: bilateral patchy areas of consolidation and ground glass opacities 
limited to the lower lobes of the lungs; locally there are single accompanying nonseptal linear opacities; B – a chest 
X-ray: massive (apparent in all lung zones) bilateral areas of consolidation without obvious volume loss. An 
extracorporeal membrane oxygenation cannula is also visible; C – marked interstitial fibrosis: this pattern was seen in 
most of lung parenchyma; D – moderate lymphocytic lung infiltrate
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